USC Stem Cell Research from Justin Ichida’s Lab Advances toward Clinical Development for ALS, following a License Agreement between Companies Takeda and AcuraStem

USC Stem Cell scientist Justin Ichida has learned to inhabit two worlds: the university where his lab makes discoveries, and the companies that can help commercialize these discoveries into new treatments for neurodegenerative diseases.